Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model

Sven A. Lang(University Hospital Regensburg), Oliver Stoeltzing(The University of Texas MD Anderson Cancer Center)

International Journal of Cancer

January 17, 2007

10.1002/ijc.22442

Cited by 167

Related Papers

Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer

|American Journal Of Pathology|2003|175

Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization <i>in vivo</i>

|Molecular Cancer Therapeutics|2007|110

ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

|BMC Cancer|2008|70

Inhibition of Heat Shock Protein 90 with AUY922 Represses Tumor Growth in a Transgenic Mouse Model of Islet Cell Neoplasms

|Neuroendocrinology|2014|9